List view / Grid view
Detection of gene abnormalities may help men determine the best…
17 April 2012 | By Abbott
Detection of gene abnormalities may help men determine the best approach to treatment...
Abbott will collaborate with Merck to evaluate the use of…
6 March 2012 | By Abbott
Abbott will collaborate with Merck to evaluate the use of a FISH-based companion diagnostic test...
Abbott announced that it will expand its existing agreement with…
28 November 2011 | By Abbott
Abbott announced that it will expand its existing agreement with GSK...
New test based on FISH technology detects chromosomal abnormality to…
24 October 2011 | By Abbott
New test based on FISH technology detects chromosomal abnormality to help predict prognosis of patients with AML...
Abbott has received 510k clearance from the FDA...
22 August 2011 | By
Abbott has received 510k clearance from the FDA...
Abbott announced it filed premarket approval applications for a new…
23 May 2011 | By Abbott
Abbott announced it filed premarket approval applications for a new molecular diagnostic test...
Abbott has received approval from the FDA to market its…
18 May 2011 | By Abbott
Abbott has received approval from the FDA to market its RealTime PCR test for measuring the viral load of hepatitis C...
